Close
Biotechgate
| |

Home Page

Action required: Please refresh your browser

We have recently implemented some changes that require a hard refresh of your browser: Please hold down the CTRL-key and press the F5 key.
After a successful hard refresh, this message should not appear anymore.

More details about this topic are available here »

News in the Life Sciences Industry

Results 10921 - 500 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
Reset 

FDA Roundup: February 2, 2024

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  U.S. Food and Drug Administration

Akel Homes Demonstrates Enthusiastic Support as Silver Benefactor for the 2024 LLS Black Tie Gala, Eager to Contribute to Life-Saving Cancer Research

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Insmed Incorporated

Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Akebia Therapeutics, Inc.

Syndax Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Syndax Pharmaceuticals, Inc.

Proven Behavior Solutions Appoints Mark Donovan to Board of Directors

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

CALIFORNIA SURGEON GENERAL VISITS SONOMA COUNTY TO PROMOTE TRAUMA INFORMED SCHOOLS

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

Spyre Therapeutics Announces Grants of Inducement Awards

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Spyre Therapeutics, Inc.

Global Medical Marijuana Market Report 2024: Market Value to Reach $154.83 Billion by 2034 from $16.88 Billion in 2023

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

Merck & Co Digital Transformation Strategy Analysis Report 2023: Accelerators, Incubators, and Other Innovation Programs

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

JMIR MEDICAL INFORMATICS INVITES SUBMISSIONS ON AI LANGUAGE MODELS IN HEALTH CARE

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024

VALEO PHARMA AMENDS AGREEMENT WITH NOVARTIS PHARMACEUTICALS CANADA FOR (Pr)XIIDRA® IN CANADA AND CREDIT FACILITY WITH SAGARD HEALTHCARE ROYALTY PARTNERS, LP

Read more ››
By: PR Newswire Association LLC. - 02 Feb 2024
Related companies:  Valeo Pharma Inc.

Regeneron Reports Fourth Quarter and Full Year 2023 Financial and Operating Results

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Regeneron Pharmaceuticals Inc.

Tisotumab Vedotin Marketing Authorization Application Validated by European Medicines Agency for Treatment of Recurrent or Metastatic Cervical Cancer

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Genmab A/S

Eton Pharmaceuticals Announces Commercial Availability of Ultra-Rare Disease Product Nitisinone Capsules

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Eton Pharmaceuticals, Inc.

BridgeBio Pharma Shares Positive Results of Single-Arm Phase 3 Study of Acoramidis in Japanese Patients with Transthyretin Amyloid Cardiomyopathy (ATTR-CM) Including No Mortality Reported in the Trial at 30 Months

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  BridgeBio Pharma, Inc.

Agios to Webcast Conference Call of Fourth Quarter and Year End 2023 Financial Results on February 15, 2024

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Agios Pharmaceuticals, Inc.

Sio Gene Therapies, Inc. to File for Dissolution and Declare an Initial Liquidating Distribution of $0.435 Per Share

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Sio Gene Therapies Inc.

Orchard Therapeutics Announces Multiple Presentations at the 20th Annual WORLDSymposium

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  Orchard Therapeutics plc

BioCryst Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

Read more ››
By: GlobeNewswire - 02 Feb 2024
Related companies:  BioCryst Pharmaceuticals, Inc.
«  1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25
to the top ↑